1-7 of 7
Yuzhang Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world safety and efficacy of aponermin and daratumumab-based regimens in patients with multiple myeloma

Free
Xiaozhe Li, Baijun Fang, Di Wang, Yuzhang Liu, Yanping Ma, Peiling Zhang, Aijun Liu, Wenming Chen, Juan Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 7580.
https://doi.org/10.1182/blood-2025-7580
Published: 2025
Journal Articles

Efficacy and safety of aponermin combined with immunomodulators in relapsed/refractory multiple myeloma

Free
Xiujuan Huang, Yanping Ma, Zhenyu Li, Juan Li, Yuzhang Liu, Yaomei Wang, Chao Song, Xiaoqi Qin, Wenming Chen, Yi Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 7571.
https://doi.org/10.1182/blood-2025-7571
Published: 2025
Journal Articles

Updated results of a first-in-human, Phase Ⅰa/Ⅰb study of QLS32015 (GPRC5D×CD3) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)

Free
Gang An, Baijun Fang, Xiaobing Huang, Yan Xu, Fei Li, Zhen Cai, Xiaojing Yan, Xianqi Feng, Wuping Li, Xiangmin Tong, Zengjun Li, Yuzhang Liu, Feifei Che, Xin'ai Yang, Xianlin Duan, Peng Shao, Xiaoyan Kang, Lugui Qiu
Journal: Blood
Blood (2025) 146 (Supplement 1): 4049.
https://doi.org/10.1182/blood-2025-4049
Published: 2025
Journal Articles

First-in-Human, Phase Ia , Dose Escalation, Monotherapy Study of QLS32015, a Novel GPRC5D×CD3 T-Cell Engaging Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Free
Lu-Gui Qiu, Gang An, Baijun Fang, Xiaobing Huang, Yan Xu, Yuzhang Liu, Feifei Che, Xinai Yang, Xianlin Duan, Peng Shao, Xiaoyan Kang
Journal: Blood
Blood (2024) 144 (Supplement 1): 1990.
https://doi.org/10.1182/blood-2024-201960
Published: 2024
Journal Articles

Efficacy and Safety of Carfilzomib-Based Regimens in Multiple Myeloma: Single-Center Real-World Experience

Free
Yaomei Wang, Xueting Wang, Yuzhang Liu, Lijie Liang, Lina Liu, Wenyi Lu, Yongping Song, Baijun Fang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7836.
https://doi.org/10.1182/blood-2024-206491
Published: 2024
Journal Articles

Phase I Study of a Novel Oral Proteasome Inhibitor TQB3602 in Relapsed/Refractory Multiple Myeloma

Free
Wenjiao Tang, Yan Li, Qiushi Liang, Ying Qu, Li Zhang, Yuzhang Liu, Baijun Fang, Zeng Yun, Xiaobo Du, Yaming Xi, Ting Wang, Xin Li, Jie Huang, Wenbin Qian, Zhen Cai, Qingwei Zhao, Yue Lv, Ting Niu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4396–4397.
https://doi.org/10.1182/blood-2022-168091
Published: 2022
Journal Articles

Autologous Hematopoietic Stem Cell Infusion for Myelosuppression after Bcma-CART Therapy in Relapsed Myeloma Patients

Free
Quande Lin, PhD, Lu Han, MS, Jian Zhou, MD PhD, Lina Liu, Master, Yuzhang Liu, master, Fengkuan Yu, Master, YangLi Zhang, Master, Wenli Zuo, Doctor, Keshu Zhou, MD, Baijun Fang, MD, Quanli Gao, Doctor, Xudong Wei, PhD, Delong Liu, MD PhD, Yongping Song, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1851.
https://doi.org/10.1182/blood-2019-128410
Published: 2019